ACR thanks WISDOM Trial researchers for exploring risk-based breast cancer screening as an alternative to annual mammography. However, the study design and results do not provide adequate information to support changes to present screening policies.
ACR thanks WISDOM Trial researchers for exploring risk-based breast cancer screening as an alternative to annual mammography. However, the study design and results do not provide adequate information to support changes to present screening policies.